Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 71205-063

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71205-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1a (22bf08c2 615b 4b48 Af36 1b71a91459dc 01)

A line graph depicting the relationship between baseline systolic blood pressure (SBP) in mmHg on the x-axis and the percentage of patients achieving SBP below 140 mmHg on the y-axis. The graph compares average and individual results from studies labeled Study V and Study VI for Irbesartan (Irb.) and HCTZ.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1b (22bf08c2 615b 4b48 Af36 1b71a91459dc 02)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) less than or equal to 130 mmHg on the y-axis, plotted against baseline SBP values ranging from 140 to 220 mmHg on the x-axis. The graph compares results from different studies labeled as Av., Irb., and HCTZ, with multiple lines corresponding to Study V and VI for Irbesartan and Hydrochlorothiazide combination therapies.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2a (22bf08c2 615b 4b48 Af36 1b71a91459dc 03)

A line graph depicting the percentage of baseline diastolic blood pressure (DBP) changes versus baseline DBP (mmHg) across different studies labeled Study V and Study VI. The variables include Av. Study V, Irb. Study V, HCTZ Study V, Av. Study VI, and Irb. Study VI, each represented with distinct line styles and colors.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2b (22bf08c2 615b 4b48 Af36 1b71a91459dc 04)

A line graph showing the percentage decrease in diastolic blood pressure (DBP) versus baseline DBP (mmHg). It includes multiple study groups such as average Study V, Irbesartan Study V, Hydrochlorothiazide Study V, average Study VI, and Irbesartan Study VI, each represented by distinct line styles and colors.*

FDA Label Image

Chemical Structure Irbesartan (22bf08c2 615b 4b48 Af36 1b71a91459dc 05)

Chemical structure diagram of the active ingredients Irbesartan and Hydrochlorothiazide, showing their molecular components and bonding arrangement.*

FDA Label Image

Chemical Structure Hydrochlorothiazide (22bf08c2 615b 4b48 Af36 1b71a91459dc 06)

Chemical structure of Irbesartan and Hydrochlorothiazide, showing molecular components with chlorine, sulfonamide groups, and other atomic bonds as depicted.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 3 (22bf08c2 615b 4b48 Af36 1b71a91459dc 07)

A scatter plot with a curve showing the placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis versus irbesartan dose (mg/day) on the x-axis, illustrating the dose-response relationship in an integrated analysis.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 4 (22bf08c2 615b 4b48 Af36 1b71a91459dc 08)

A scatter plot with an overlaid curve illustrating placebo-subtracted reduction in trough seated systolic blood pressure (SeDBP) plotted against irbesartan dose in milligrams. Data points are scattered with a trend of increasing blood pressure reduction as dosage rises, leveling off at higher doses, ranging from 0 to around 900 mg on the x-axis and -2 to 8 mmHg on the y-axis.*

FDA Label Image

71205-063-30 (22bf08c2 615b 4b48 Af36 1b71a91459dc 09)

Label for Irbesartan 150 mg and Hydrochlorothiazide 12.5 mg tablets by Proficient Rx LP. The label states RX only and includes a count of 30 tablets. Tablets are described as pink, capsule-shaped, debossed with '325' and 'HH'. Manufacturer is Zhejiang Huahai Pharmaceutical Co., Ltd, China. Storage and safety instructions are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.